Lung Cancer Treatment Response Varies by Emphysema Presence, Study Finds

A new study reveals that the tumor microenvironment in lung adenocarcinoma can differ significantly based on a patient's smoking history and whether they also have emphysema. This finding suggests that these factors could influence the effectiveness of immunotherapy.

“

This study shows that even with the same lung adenocarcinoma diagnosis, the tumor microenvironment can form differently depending on smoking history and the presence of emphysema.

The research, conducted by a team at Yeouido St. Mary's Hospital, analyzed immune gene expression in tissue samples from 12 patients who underwent surgery for lung adenocarcinoma. The patients were categorized into three groups: non-smokers without emphysema, smokers without emphysema, and smokers with emphysema.

Analysis showed varying immune gene expression patterns across the groups. Notably, patients with both smoking history and emphysema exhibited increased expression of certain genes associated with inflammation and tissue modification, compared to smokers without emphysema. The study also found correlations between lung diffusion capacity and specific immune genes, indicating a potential link between lung function decline and the tumor's immune surroundings.

“

Precise analysis of patient tissues could aid in developing more tailored treatment plans.

"This study shows that even with the same lung adenocarcinoma diagnosis, the tumor microenvironment can form differently depending on smoking history and the presence of emphysema," said Professor Im Jeong-wook, the study's lead author. He added that precise analysis of patient tissues could aid in developing more tailored treatment plans. The research also highlighted the value of multidisciplinary collaboration among departments like pulmonology, thoracic surgery, and pathology in advancing clinical practice and research.

“

This research highlights the value of multidisciplinary collaboration among departments like pulmonology, thoracic surgery, and pathology in advancing clinical practice and research.